Sex differences in the course of schizophrenia across diverse regions of the world
Diego Novick,1 William Montgomery,2 Tamas Treuer,3 Maria Victoria Moneta,4 Josep Maria Haro4 1Eli Lilly and Company, Windlesham, Surrey, UK; 2Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia; 3Eli Lilly and Company, Neuroscience Research, Budapest, Hungary; 4Parc Sanitari Sant Joan de D&e...
Guardado en:
Autores principales: | Novick D, Montgomery W, Treuer T, Moneta MV, Haro JM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/31853c122c8e4fdf878927e63784e87a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Perceived stress, quality of life, and coping skills among patients with schizophrenia in symptomatic remission
por: Sheikh Shoib, et al.
Publicado: (2021) -
Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients
por: Suguru Nakajima, et al.
Publicado: (2021) -
Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review
por: Karson C, et al.
Publicado: (2016) -
Long-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia
por: Natalia N. Petrova, et al.
Publicado: (2020) -
Psychosocial Effects of the COVID-19 Pandemic on Patients With Schizophrenia and Their Caregivers
por: Alejandra Caqueo-Urízar, et al.
Publicado: (2021)